Filing Details
- Accession Number:
- 0000950170-24-116048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-21 20:22:37
- Reporting Period:
- 2021-05-03
- Accepted Time:
- 2024-10-21 20:22:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1341235 | Aldeyra Therapeutics Inc. | ALDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1735084 | Nancy Miller-Rich | C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue Lexington MA 02421 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-03 | 413 | $12.81 | 413 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-04-12 | 509 | $10.13 | 922 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported herein were executed under the trading discretion of an investment advisor in a managed account, without any instruction from or knowledge of the Reporting Person. The Reporting Person only recently become aware of these transactions.